RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/23954132http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/23954132http://www.w3.org/2000/01/rdf-schema#comment"Liver fibrosis is a consequence of chronic liver diseases and thus a major cause of mortality and morbidity. Clinical evidence and animal studies suggest that local tissue homeostasis is disturbed due to immunological responses to chronic hepatocellular stress. Poorly defined stress-associated inflammatory networks are thought to mediate gradual accumulation of extracellular-matrix components, ultimately leading to fibrosis and liver failure. Here we have reported that hepatic expression of interleukin-33 (IL-33) was both required and sufficient for severe hepatic fibrosis in vivo. We have demonstrated that IL-33's profibrotic effects related to activation and expansion of liver resident innate lymphoid cells (ILC2). We identified ILC2-derived IL-13, acting through type-II IL-4 receptor-dependent signaling via the transcription factor STAT6 and hepatic stellate-cell activation, as a critical downstream cytokine of IL-33-dependent pathologic tissue remodeling and fibrosis. Our data reveal key immunological networks implicated in hepatic fibrosis and support the concept of modulation of IL-33 bioactivity for therapeutic purposes."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.org/dc/terms/identifier"doi:10.1016/j.immuni.2013.07.018"xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Walker J."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Waldner M."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Neurath M.F."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Schuchmann M."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Pflanz S."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"McKenzie A.N."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Wirtz S."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Voehringer D."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Rankin A.L."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"McHedlidze T."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/author"Zopf S."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/date"2013"xsd:gYear
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/name"Immunity"xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/pages"357-371"xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/title"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis."xsd:string
http://purl.uniprot.org/citations/23954132http://purl.uniprot.org/core/volume"39"xsd:string
http://purl.uniprot.org/citations/23954132http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/23954132
http://purl.uniprot.org/citations/23954132http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/23954132
http://purl.uniprot.org/uniprot/#_A0A0U1RNW1-mappedCitation-23954132http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23954132
http://purl.uniprot.org/uniprot/#_A0A0U1RPZ6-mappedCitation-23954132http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23954132
http://purl.uniprot.org/uniprot/#_A2VCP1-mappedCitation-23954132http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23954132
http://purl.uniprot.org/uniprot/#_D3Z6T7-mappedCitation-23954132http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23954132